ixc107

Inna Chervoneva, PhD

Contact Dr. Chervoneva

1015 Chestnut Street
Suite 520
Philadelphia, PA 19107

(215) 955-4083
(215) 503-3804 fax

Most Recent Peer-reviewed Publications

  1. Effects of dextroamphetamine in subacute traumatic brain injury: A randomized, placebo-controlled pilot study
  2. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls
  3. Changes in cerebellar functional connectivity and autonomic regulation in cancer patients treated with the Neuro Emotional Technique for traumatic stress symptoms
  4. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
  5. Bimodal coupling of ripples and slower oscillations during sleep in patients with focal epilepsy
  6. Neuro emotional technique effects on brain physiology in cancer patients with traumatic stress symptoms: preliminary findings
  7. Buprenorphine for the treatment of the neonatal abstinence syndrome
  8. Extensions of D-optimal minimal designs for symmetric mixture models
  9. Modeling qRT-PCR dynamics with application to cancer biomarker quantification
  10. Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas
  11. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer
  12. How Do Intensity and Duration of Rehabilitation Services Affect Outcomes From Severe Traumatic Brain Injury? A Natural Experiment Comparing Health Care Delivery Systems in 2 Developed Nations
  13. Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
  14. An in vivo reporter to quantitatively and temporally analyze the effects of CDK4/6 inhibitor-based therapies in melanoma
  15. RhoA inhibits neural differentiation in murine stem cells through multiple mechanisms
  16. Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes
  17. Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers
  18. Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein
  19. Prevalence, Risk Factors, and Correlates of Anxiety at 1 Year after Moderate to Severe Traumatic Brain Injury
  20. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells